Mary Yursky
Gastroenterology · North Ridgeville, OHNPI 1144246570
Payments from drug & device makers
Across 188 payments — averaging $40.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$2K
- Pfizer$362
- Takeda Pharmaceuticals U.S.A., Inc.$331
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$151
- Bristol Myers Squibb$147
- plus $1K from 16 others
What the payments were for
- Consulting fees$3,00039%
- Food & beverage$4,69461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $3,311 |
| AbbVie | 79 | $2,194 |
| Pfizer | 14 | $362 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $331 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $151 |
| Bristol Myers Squibb | 4 | $147 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 7 | $125 |
| Merck | 7 | $123 |
| Sanofi | 5 | $112 |
| Lilly USA, LLC | 5 | $107 |
| Braintree Laboratories, Inc. | 6 | $102 |
| E.r. Squibb & Sons, L.L.C. | 1 | $99 |
| Ardelyx, Inc. | 4 | $83 |
| Ironwood Pharmaceuticals, Inc | 4 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| QOL Medical, LLC | 3 | $55 |
| Nestle Healthcare Nutrition Inc. | 3 | $54 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $14 |
| Celltrion USA Inc. | 1 | $14 |
| Organon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,694 in reported general payments places this provider in the 65th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $174,076 |
| Pantoprazole Sodium | 31 | $960 |
| Omeprazole | 65 | $902 |
| Esomeprazole Magnesium | 12 | $671 |
| Dicyclomine Hcl | 22 | $358 |
| Famotidine | 12 | $214 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in North Ridgeville
- Naim AlkhouriWestlake$10.1M
- Florian RiederCleveland$8.7M
- Keith FriedenbergMentor$5M
- Anita AfzaliCincinnati$2.4M
- Pierre GholamCleveland$1.9M
- Benjamin CohenCleveland$1.9M
- Mohamed NaemWestlake$1.6M
- Mousab TabbaaWestlake$1.4M
- Pradeep BekalCincinnati$1.4M
- Na LiColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.